|
|
Vaccine Detail
|
live attenuated Brucella melitensis delta Omp25 vaccine |
| Vaccine Information |
- Vaccine Name: live attenuated Brucella melitensis delta Omp25 vaccine
- Target Pathogen: Brucella spp.
- Target Disease: Brucellosis
- Vaccine Ontology ID: VO_0009147
- Type: Live attenuated vaccine
- Status: Research
- Host Species for Licensed Use: Goat
- Host Species as Laboratory Animal Model: Mus musculus (BALB/c mice)
- Antigen: Omp25 deletion (Deltaomp25)
- Preparation: Live attenuated Brucella melitensis strain with omp25 gene disruption (BM25). (Edmonds et al., 2002)
- Description: Omp25 was examined as a potential vaccine candidate by creating a mutant strain with disruption of the omp25 gene. Efficacy: Vaccination with BM25 resulted in more than a 2 log10 reduction in bacterial load following challenge with virulent B. melitensis (P<0.01). (Edmonds et al., 2002)
|
| Host Response |
|
Mouse Response
- Host Strain: BALB/c
- Challenge Protocol: BALB/c mice were vaccinated with BM25 and challenged with virulent Brucella melitensis; bacterial loads in spleens were measured. (Edmonds et al., 2002)
- Efficacy: Vaccination with BM25 resulted in more than a 2 log10 reduction in bacterial load following challenge with virulent B. melitensis (P<0.01). (Edmonds et al., 2002)
- Description: BALB/c mice were vaccinated with BM25 and challenged with virulent Brucella melitensis; bacterial loads in spleens were measured. (Edmonds et al., 2002)
|
| References |
Edmonds et al., 2002: Edmonds MD, Cloeckaert A, Elzer PH. Brucella species lacking the major outer membrane protein Omp25 are attenuated in mice and protect against Brucella melitensis and Brucella ovis. Veterinary microbiology. 2002; 88(3); 205-221. [PubMed: 12151196].
|
|